Nilutamide Tablet — FDA Drug Shortage

To Be Discontinued — Advanz Pharma (US) Corp.

The FDA lists a drug shortage record for Nilutamide Tablet (tablet) from Advanz Pharma (US) Corp. with status To Be Discontinued. The shortage was first posted on Dec 1, 2025.

Shortage details

Status
To Be Discontinued
Company
Advanz Pharma (US) Corp.
Package NDC
66993-212-38
Dosage Form
Tablet
Presentation
Nilandron, Tablet, 150 mg (NDC 66993-212-38)
Initial Posting
Dec 1, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.